Infectious diseases are disorders caused by several pathogenic
organisms such as bacteria, viruses, fungi or parasites. These diseases can be transmitted
or spread from one person to another through direct contact or indirect
contact. Anti-infective drugs are used to treat or prevent these infectious
diseases by inhibiting the spread of an infectious agent (static) or by killing
the infectious agent (cidal).
Order report at
The anti-infective drugs global
market has shown moderate growth in the past years with a CAGR of around 3%.
The year 2017 recorded highest ever market value in this industry as per TBRC’s
in-house consultants.
TBRC’s latest report show the historic and future trends in
the market for each year with sourced reasons to support the growth claims.
The report also shows the anti-infective
drugs market to grow at a higher CAGR by 2021 as compared to 2017, along
with geographies best suited for investments with highest return rate.
Download report at
Antivirals
was the largest segment in the anti-infective drugs market, accounting for 50.8%
of the market. This can be attributed to the high prevalence of diseases such
as HIV/AIDS, hepatitis, Ebola, smallpox caused by viral infections. Moreover,
viral infections can spread through body fluids or transmitted by air which
increased the use of antivirals.
Companies included in the report
are Gilead, Merck & Co., Glaxosmith Kline,
Bristol-Myers Squibb Company and Johnson & Johnson.
The Business Research Company is a Business
Intelligence Company which excels in company, market and consumer research. It
has offices in the UK, the US and India and a network of trained researchers in
15 countries globally.
Contact
Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
No comments:
Post a Comment